Piramal Enterprises — Piramal Pharma Solutions
Tracked across 4 events · 45 articles · First seen Apr 16, 2026 · Last active Aug 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Piramal Enterprises — Piramal Pharma Solutions entered a strategic collaboration with Ajinomoto Bio-Pharma Services to enhance ADC development and manufacturing programs, expanding its capabilities and market reach.
Apr 16, 2026 · 11 articles
Business
Impact: Piramal Enterprises — Piramal Pharma Solutions unveiled a new payload-linker development and manufacturing suite, enhancing its U.S.-based manufacturing capabilities and strengthening its position in the bioconjugate therapies market.
May 13, 2026 · 11 articles
Business
Piramal Enterprises — Piramal Pharma Solutions (PPS), a CDMO and part of Piramal Group, launched a new spray drying suite at its dedicated peptide development and manufacturing facility in Turbhe, India. The suite is a…
Impact: Directly expanded its peptide facility with new spray drying suite, strengthening its service offering.
Aug 04, 2026 · 12 articles
Business
On August 18, 2026, Piramal Group (PPL) completed the acquisition of an additional 40.67% stake in Yapan Bio, a Hyderabad-based CDMO specializing in vaccines and biologics, for a cash consideration of ₹76 crore (approximately $7.95…
Impact: CDMO arm of PPL; will operate Yapan Bio, enhancing its biologics and ADC development services.
Jul 20, 2026 · 11 articles
80
Piramal Enterprises — Piramal Pharma Solutions launched spray drying suitePiramal Pharma Solutions...
ERGEN INTELLIGENCE
Track Piramal Enterprises — Piramal Pharma Solutions live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard